Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia

Blood

Volumn 91, Issue 8, 1998, Pages 2793-2799

  Hasegawa, Daiichiro ^b   Kojima, Seiji ^b   Tatsumi, Eiji ^b   Hayakawa, Akira ^b   Kosaka, Yoshiyuki ^b   Nakamura, Hajime ^b   Sako, Masahiro ^b   Osugi, Yuko ^b   Nagata, Shigekazu ^b   Sano, Kimihiko ^a  

^a KOBE UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GAMMA INTERFERON;

ADOLESCENT; ARTICLE; BLACKFAN DIAMOND ANEMIA; CHILD; CLINICAL ARTICLE; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; INFANT; LYMPHATIC LEUKEMIA; LYMPHOMA; MALE; NATURAL KILLER CELL; NEWBORN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0032522964     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.8.2793.2793_2793_2799     Document Type: Article

References (43)

1. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
2. + human marrow cells is induced by interferon-γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
3. Nagafuji K, Shibuya T, Harada M, Mizuno S, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883, 1995
4. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family. Cell 75:1169, 1993
5. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189, 1995
6. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314. 1992
7. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969, 1994
8. Fisher GH, Rosemberg FJ, Straus SE, Dale JK, Middleton LA, Lin AJ, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935, 1995
9. Rieux-Laucat F, Le-Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de-Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347, 1995
10. Giordano C, Stassi G, De-Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960, 1997
11. Kondo T, Suda T. Fukuyama H, Adachi M, Nagata S: Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3:409, 1997
12. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nat Med 2:317, 1996
13. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of a human Fas ligand in activated lymphocytes. EMBO J 14:1129, 1995
14. Tanaka M, Suda T, Yatomi T, Nakamura N, Nagata S: Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J Immunol 158:2303, 1997
15. Henter J-I, Elinder G, Ost A, the FHL Study Group of the Histiocyte Society: Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 18:29, 1991
16. Brown KE, Tisdale J, Barret J, Dunbar CE, Young NS: Hepatitis-associated aplastic anemia. N Engl J Med 336:1059, 1997
17. Halperin DS, Freedman MH: Diamond-Blackfan anaemia: Etiology, pathophysiology, and treatment. Am J Pediatr Hematol Oncol 11:380, 1989
18. Saito I, Servenius B, Compton T, Fox RI: Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 169:2191, 1989
19. + cells of patients with aplastic anaemia. Br J Haematol 91:245, 1995
20. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature 364:806, 1993
21. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
22. Yano H, Fukuda K, Haramaki M, Momosaki S, Ogasawara S, Higaki K, Kojiro M: Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines. J Hepatol 25:454, 1996
23. Imashuku S, Hibi S, Fujiwara F, Ikushima S, Todo S: Haemophagocytic lymphohistiocytosis, interferon-gamma-anemia and Epstein-Barr virus involvement. Br J Haematol 88:656, 1994
24. Rickinson AB: Cellular immunological responses to the virus infection, in Epstein MA, Achong BG (eds): The Epstein-Barr Virus: Recent Advances. New York, NY, Wiley, 1990, p 75
25. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH, Simmons RL, Brunning RD: Virus-associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993, 1979
26. Arico M, Janka G, Fisher A, Henter JI, Blanche S, Elinder G, Maritinetti M, Ruska MP: Hemophagocytic lymphohistiocytosis. Report of 122 children from the international registry. Leukemia 10:197, 1996
27. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L: Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223, 1995
28. Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T: Interferon-γ induces ICE gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 229:21, 1996
29. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY: Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131:1300, 1983
30. Sechler JM, Malech HL. White CJ, Gallin JI: Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci USA 85:4874. 1988
31. Young HA, Klinman DM, Reynolds DA, Grzegorzewski KJ, Nii A, Ward JM, Winkler-Pickett RT, Ortaldo JR, Kenny JJ, Komschilies KL: Bone marrow and thymus expression of interferon-γ results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies. Blood 89:583, 1997
32. Líles WC, Kíener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429, 1996
33. Rosenfeld SJ, Kimball J, Vining D, Young NS: Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85:3058, 1995
34. Nakao S, Yamaguchi M, Shiobara S, Yokoi T, Miyawaki T, Taniguchi T, Matsuda T: Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 79:2532, 1992
35. Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS: Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 22:1102, 1994
36. Nakao S, Takami A, Takamatsu H, Zeng W, Sugimori N, Yamazaki H, Miura Y, Ueda M, Shiobara S, Yoshioka T, Kaneshige T, Yasukawa M, Matsuda T: Isolation of a T-cell clone showing HLADRB1 * 0405-restricted cytotoxicity for hematopoietíc cells in a patient with aplastic anemia. Blood 89:3691, 1997
37. Nakao S: (1997) Expression of Fas gene in aplastic anemia, in Takaku F, Miyazaki S, Saito H, Mizoguchi H, Sakata Y (eds): Annual Review Ketsueki. Tokyo, Japan, Chugai Igakusha, 1997, p 43 (in Japanese)
38. Dianzani I, Garelli E, Dompe C, Crescenzio N, Locatelli F, Schillo G, Castaman G, Bagnara GP, Olivieri NF, Gabutti V, Ramenghi U: Mutations in the erythropoietin receptor gene are not a common cause of Diamond-Blackfan anemia. Blood 87:2568, 1996
39. Abkowitz JL, Broudy VC, Benet LG, Zsebo KM, Martin FH: Absence of abnormalities of c-kit or its ligand in two patients with Diamond Blackfan anemia. Blood 79:25, 1992
40. Drachtman RA, Geissler EN, Alter BP: The SCF and c-kit genes in Diamond Blackfan anemia. Blood 79:2177, 1992
41. Hoffman R, Zanjani ED, Vila J, Zalusky R, Lutton JD, Wasserman LR: Diamond-Blackfan syndrome: Lymphocyte-mediated suppression of erythropoiesis. Science 193:899, 1976
42. Steinberg MH, Coleman MF, Pennebaker JB: Diamond-Blackfan syndrome: Evidence for T-cell mediated suppression of erythroid development and a serum blocking factor associated with remission. Br J Haematol 41:57, 1979
43. Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J, Picard F, Dreyfus F, Fontenay-Roupie M: Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia 11:839, 1997